VRTX
Vertex Pharmaceuticals Incorporated
$425.57
+$5.68(+1.35%)
62
Overall
45
Value
75
Tech
68
Quality
Market Cap
$108.30B
Volume
1.50M
52W Range
$362.50 - $519.88
Target Price
$490.60
Key Metrics Overview
| Market Cap | $108.30B | P/E Ratio | 26.78 |
| 52W High | $519.88 | 52W Low | $362.50 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -30.6% | 52W Position | 40.1% |
| Overall Score | 62 | Value Score | 45 |
| Quality Score | 68 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $15.89 | EPS Next Est | $17.45 |
| EPS Growth Est | +9.8% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $425.57 | +1.4% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW